Skip to content
‹ Back to IndustriesHealthcare

CDC Guidelines “Really Not Workable” According to Carnival CEO

U.S. cruises could resume by mid-summer with restrictions, the Centers for Disease Control and Prevention said. Carnival Chief Executive Officer Arnold Donald said the agency’s restrictions were “not workable,” and that the company considered setting its ships to sail from outside the U.S. Donald spoke with Bloomberg’s Carol Massar.   Donald: The CDC, I think,…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

·
Share

Free workspace

Turn your Healthcare expertise into content.

Record interviews, organize footage, and write with AI on a free trial of the MarketScale platform for qualifying companies. No demo required, no credit card.

Try it Free

U.S. cruises could resume by mid-summer with restrictions, the Centers for Disease Control and Prevention said. Carnival Chief Executive Officer Arnold Donald said the agency’s restrictions were “not workable,” and that the company considered setting its ships to sail from outside the U.S. Donald spoke with Bloomberg’s Carol Massar.

Donald: The CDC, I think, last October issued a conditional sail order and they came out in phases, the first phase was bringing ships back into us waters and it was primarily with minimal crew on board. We finished that phase of it in terms of having ourselves, 30 ships that are currently in green status. They issued on April 2nd, the next phase. And frankly, what has been issued doesn’t give us a specific time to be able to return and also is really not workable in the current form. But again, it just came out. And we have an opportunity to discuss with the CDC and the administration to make sure that we do have something that’s workable and hopefully that will allow us to be able to sail in July.

We’re hoping it will be something that’s more in line with the advancements of vaccines that’s occurred and the rapid advancement of the vaccines that the administration has been so successful with, as well as the advancement in treatments and the investments, the rapid testing, none of which existed when the original conditional sail order was written. So we’re hopeful that we’ll be able to meet with the administration and CDC and come up with something that’s practical and will allow people to return to their choice of vacation travel and get a whole lot of Americans back to work. As you know half million people were impacted in the US in terms of jobs associated with the cruise industry outside of the cruise companies themselves.

Host: It affects a lot of other jobs and other industries connected with the cruise industry. One thing I got to ask you, Arnold, is how much of Carnival threatening to relocate their ships to other markets outside the United states, do you think was the reason for the CDC change? Because it was just a few days ago that they came out, you know, and we’re still kind of holding firm what happened? What were the conversations that maybe you, you and other members of the cruise line industry had with the CDC?

Donald: There was no threat or anything, it’s just a practical reality that if we’re not able to sail from the US sometime soon, we would have to sail from elsewhere. And so some of the ships, what homeport in a number of companies have already announced home 40 ships that normally would have been selling out of the US home ported from different places in the Caribbean. But it’s not a threat or anything. It’s just a natural outcome of not being able to sail, you know, from the US. I’m not sure anything has changed. Perhaps it has. I haven’t heard directly from the CDC or the administration anything has changed. I think that they genuinely believe the information they put out might allow some limited sailing as early as July. And so we’ll have to discuss that with them. You know, our timelines don’t quite match up with that, but maybe we don’t understand everything.

The CDC has a job to do. They’re trying to do their job. I think as long as we work together with the CDC and the administration, we can all get crews, you know, back soon. And we can have all those half a million workers no longer suffer from not being able to earn a wage.

—

*Bloomberg contributed to this content

Follow us on social media for the latest updates in B2B!

Twitter – @MarketScale

Facebook – facebook.com/marketscale

LinkedIn – linkedin.com/company/marketscale

Video TranscriptExpand ↓

The CDC, I think, last October issued a conditional sale order and they came out in phases, the first phase was bringing ships back into us waters and it was primarily with minimal crew on board. We finished that phase of it in terms of having it ourselves, 30 ships that are currently in green status. They issued on April 2nd, the next phase. And frankly, what has been issued doesn't give us a specific time to be able to return and also is really not workable in the current form. But again, it just came out. And we have an opportunity to discuss with the CDC and the administration to make sure that we do have something that's workable and hopefully that will allow us to be able to sail in July. And we're hoping it will be something that's more in line with the advancements of vaccines that's occurred and the rapid advancement of the vaccines that the administration has been so successful with, as well as the advancement and treatments and the investments, the rapid testing, none of which existed when the original conditional sale order was written. So we're hopeful that we'll be able to meet with the administration and CDC and come up with something that's practical and will allow people to return to their choice of vacation travel and get a whole lot of Americans back to work. As you know, Carol, of a half million people impacted in the US in terms of jobs associated with the cruise industry outside of the cruise companies themselves. Now, it affects a lot of other jobs. And other industries connected with the cruise industry. One thing I got to ask you, Arnold, is how much of carnival threatening to relocate their ships to other markets outside the United states, do you think was the reason for the CDC change? Because it was just a few days ago that they came out, you know, and we're still kind of holding firm what happened? What were the conversations that maybe you, you and other members of the cruise line industry had with the cdc? There was no threat or anything, it's just a practical reality that if we're not able to seal from the US and some monsoon, we would have to steal from elsewhere. And so some of the ships, what homeport in a number of companies have already announced home 40 ships that normally would have been selling out of the US home ported from different places in the Caribbean. But it's not a threat or anything. It's just a natural outcome of not being able to sail, you know, from the u.s., I'm not sure anything has changed. Perhaps it has. I haven't heard directly from the CDC or the administration anything has changed. I think that they genuinely believe the information they put out might allow some limited sailing as early as July. And so we'll have to discuss that with them. You know, our timelines don't quite match up with that, but maybe we don't understand everything. So the CDC has a job to do. They're trying to do their job. I think as long as we work together with the CDC and the administration, we can all get cruise, you know, back soon. And we can get it back. And safe was in the interest of public health. And we can have all those half a million workers no longer suffer from not being able to earn a wage.

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Book DemoSee how it works15 minutes, straight to a calendar.
B2B Weekly

The week in Healthcare, and sixteen other industries, every Monday.

Ten stories, one-line takes, five minutes. Free.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. Explore how your experts, customers, and partners can become useful content for buyers and AI search.

Free Trial

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Start a free trial and see it with your own people. For qualifying companies, no credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What your free trial includes

Hands-on access to the MarketScale platform
Media requests to your crowd, remote recording, AI writing tools
No demo required. No credit card.
For qualifying companies. Company confirmation required.

More Healthcare Insights

Luminopia's CEO says payer churn slows coverage and can require patching first

Luminopia's CEO says payer churn slows coverage and can require patching first

Luminopia co-founder and CEO Scott Xiao told HLTH's Partner Highlight series that short payer member tenure and a fragmented Medicaid leave pediatric amblyopia neglected. A 2025 JMCP payer roundtable recommended covering the FDA-authorized therapy but allowed step-edits, while PEDIG data show two-hour patching adds about 1.1 lines of acuity. Cleveland Clinic registry data report 1.8 lines of gain in severe cases.

  • 01A 2025 payer roundtable in the Journal of Managed Care & Specialty Pharmacy recommended plans cover Luminopia, yet said step-edits and letters of exception may still be required, with more than 9,000 prescriptions written since November 2022.
  • 02PEDIG's ATS05 trial put two hours of daily patching at 1.1 lines of gain over five weeks versus 0.5 lines for glasses alone, while a 2015 AAO review tied patching's poor compliance to social stigma.
  • 03S.1702, the Access to Prescription Digital Therapeutics Act of 2025, has sat in the Senate Finance Committee since May 8, 2025, leaving coverage negotiated plan by plan.

Nov 19, 2026

AHA and BD's 10-hospital pilot tests who acts on surgical blood pressure readings

AHA and BD's 10-hospital pilot tests who acts on surgical blood pressure readings

The American Hospital Association, West Health and BD will add continuous blood pressure monitoring to surgical care at 10 hospitals, with Vizient measuring results. The pilot tests the workflow around the device: who notices a change, who acts and who hands it off. Whether it spreads depends on cost after startup funding ends.

  • 01A monitor running in two operating rooms can support two different decisions, so device usage counts can say little about whether continuous blood pressure monitoring actually changed surgical care.
  • 02Hospitals evaluating continuous monitoring may already own idle devices; learning why they sit unused, whether training time or an awkward spot in the workflow, points to a different fix than a new purchase order.
  • 03A playbook is expected in roughly a year, aiming to define essential steps while leaving room for smaller or resource-limited hospitals—such as those without 24/7 pharmacy coverage—to adapt workflows locally.

Nov 19, 2026

Four renewal questions that can bring HbA1c closer to the dental chair

Four renewal questions that can bring HbA1c closer to the dental chair

Dr. Deepashree Rajendraprasad, a dentist turned hospital business intelligence developer, gives dental practices four questions for software vendors at contract renewal. They cover HL7 FHIR APIs, health information exchange access, SNODENT terminology and electronic referrals. The standards already exist. The payoff shows up chairside in anticoagulant screening, diabetes-guided periodontal care and bisphosphonate surgical planning.

  • 01Rajendraprasad argues that HbA1c is often already structured in medical systems; getting it to the dental chair starts with what a practice asks its software vendor.
  • 02Two of the five FHIR resources most relevant to dentistry, Patient and Observation, belong to the normative core of FHIR Release 4, where future changes are meant to stay backward compatible.
  • 03At renewal, ask vendors specifics: which FHIR resources they expose, whether they can query the regional HIE, whether they code in SNODENT, and whether they support structured referrals.

Nov 18, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a Demo

Or call us. No forms required. We pick up. 214-945-2512